Abstract
COPD is a complex disease with multiple pathological components, which we unfortunately tend to ignore when spirometry is used as the only method to evaluate the disorder. Additional measures are needed to allow a more complete and clinically relevant assessment of COPD. The earliest potential risk factors of disease in COPD are variations in the genetic background. Genetic variations are present from conception and can determine li felong changes in enzyme activities and protein concentrations. In contrast, measurements in blood, sputum, exhaled breath, broncho-alveolar lavage, and lung biopsies may vary substantially over time. The identification of inflammatory mediators and understanding their interactions is important for the development of anti-inflammatory treatments for this important disease. Chronic lung inflammation appears to contribute to the pathogenesis of COPD, and markers of this process have promising predictive value in COPD. To implement markers for COPD in clinical practice, besides those already established for the α 1-antitrypsin gene, further research and validation studies are needed. This review explores potential markers of early disease and prognosis in COPD by examining genetic markers in the α 1-antitrypsin, cystic fibrosis transmembrane conductance regulator (CFTR), and MBL-2 genes, and by examining the biochemical markers fibrinogen and C-reactive protein (CRP), which correlate with degree of pulmonary inflammation during stable conditions of COPD.
References
Vestbo J. (2013) Global Initiative for Chronic Obstructive Lung Disease. 01-07.
Reilly J J, Silverman E K. Shapiro S D. In Longo D. Fauci
A. Kasper D. Hauser S. Jameson J. Loscalzo J. “Harrison's Principles of Internal Medicine” (18th Ed.). McGraw Hill, 2151-2159, 2011
Decramer M. Janssens W. Miravitlles M. (2012) Lancet. 379 (9823): 1341-1351.
Rabe K F. Hurd S. Anzueto A. Barnes P J. Buist S A. Calverley P. Fukuchi Y. Jenkins C. Rodriguez R R. Vanweel C. Zielinski J. (2007) Am. J. Respir. Crit. Care Med. 176 (6): 532–55.
The 10 leading causes of death in the world, 2000 and 2011 World Health Organization. July 2013. Retrieved November 29, 2013.
Mathers C D. Loncar D. (2006) PLoS Med. 3(11):442
Lomborg B. Global problems, local solutions: costs and benefits. Cambridge University Pres. 143-144, 2013
Vestbo J. (2013) Global Initiative for Chronic Obstructive Lung Disease. 09-17.
Pirozzi C. Schol M B. (2012) Med. Clin. North Am. 96 (4): 849-67.
Mackay A J. Hurst J R. (2012) Med. Clin. North Am. 96 (4): 789-809.
Poole P J. Chacko E. Wood-Baker R W. Cates C J. (2006) Cochrane Database Syst Rev.
Halbert R J. Natoli J L. Gano A. (2006) Eur Respir J. 28: 523-532.
Calverley P M. Walker P. (2003) Lancet. 362: 1053- 1061.
Ferrer M. Alonso J. Morera J. (1997) Ann Intern Med. 127: 1072-1079.
Schols A M. Broekhuizen R. Weling-Scheepers C A. (2005) Am J Clin Nutr. 82:53-59.
Debigare R. Cote C H. Maltais F. (2001) Am J Respir Crit Care Med. 164:1712-1717.
Di Francia M. Barbier D. Mege J L. (1994) Am J Respir Crit Care Med. 150:1453-1455.
Takabatake N. Nakamura H. Abe S. (1999) Am J Respir Crit Care Med. 159:1215-1219.
Eid A A. Ionescu A A. Nixon L S. (2001) Am J Respir Crit Care Med. 164:1414-1418.
Itoh T. Nagaya N. Yoshikawa M. (2004) Am J Respir Crit Care Med. 170: 879-882.
Schols A M. Soeters P B. Dingemans A M. (1993) Am Rev Respir Dis. 147:1151-1156.
Cosio M. Ghezzo H. Hogg J C. (1987) N Engl J Med. 298:1277-1281.
Fletcher C. Peto R. (1977) BMJ. 1:1645-1648.
Lorig K R. Sobel D S. Stewart A L. Brown Jr. B S. Bandura A. Ritter P. Gonzalez V M. Laurent D D. Holman H R (1999). Medical Care 37, 5-14.
Worth H. Dhein Y. (2004) Patient Education and Counselling. 2, 267-270.
Gallefoss F (2004). Patient Education and Counselling. 52, 259-266.
WHO. (2004).The Global Burden of Disease Update.
Barnes P J. Shapiro S D. Pauwels R A. (2003) Eur Respir. J. 2; 6722-88.
Hogg J C. (2004). Lancet. 364:709-21.
Cosio M G. Saetta M. Agusti A. (2009) N Engl J Med. 360:2445-54.
Woolhouse I S. Bayley D L. Stockley R A. (2002) Thorax 2002; 57: 667-671.
Yamamoto C. Yoneda T. Yoshikawa M. (1997) Chest. 112:505-510.
Keatings V M. Collins P D. Scott D M. Barnes P J. (1996) Am J Respir Crit Care Med. 153:530-534.
Keatings V M. Barnes P J. (1997) Am J Respir Crit Care Med. 155: 449-453.
Crooks S W. Bayley D L. Hill S L. Stockley RA. (2000) Eur Respir J. 15: 274-280.
Woolhouse IS, Bayley DL, Stockley R A. (2002) Thorax. 57:709-714.
Saetta M. Di Stefano A. Turato G. (1998) Am J Respir Crit Care Med. 157: 822-826.
Crit Care Med. 157: 822-826. Gan W Q. Man S F. Senthilselvan A. Sin D D. (2004) Thorax. 59:574-580.
Sin D D. Lacy P. York E. Mann S F P. (2004) Am J Respir Crit Care Med.170:760-765.
Chinn S. (2002) Thorax. 57:393-395.
Postma D S. Kerstjens H A. (1998) Am J Respir Crit Care Med. 158: S187-S192.
Anthonisen N R. Connett J E. Kiley J P. (1994) JAMA. 272: 1497-1505.
Stockley R A. O’Brien C. Pye A. Hill S L. (2000) Chest. 117:1638-1645.
Celli B R. Cote C G. Marin J M. (2000) N Engl J Med. 350: 1005-1012.
Satyanarayana U. Chakrapani U. Biochemistry. Arunabha Books and Allied (P) Ltd. 8/1 Chintamoni Das Lane, Kolkata. 2007;3: pp.735.
Kindt T J. Barbara A. Osborne R A. Kuby J. Kuby Immunology. W. H. Freeman, 2007; 5th Edition, pp.21-54, 276-298.
Jadwiga A. Wedzicha M D. (2002) Chest. 121:136-41.
Pease J E. Williams T J. (2002) Academic Press. 255-60.
Chung K F. (2001) Eur Respir J. 18: 50-59.
Keatings V M. Collins P D. Scott D M. (1996) Am J Resp Crit Care Med.153:530-34.
Barnes P J. (2000) Chest. 117(2):10S–114.
Bhowmik A. Seemungal T A. Sapsford R J. Wedzicha J A. (2000) Thorax. 55(2):114-20.
Landbo C. Prescott E. Lange P. Vestbo J. Almdal T P.(1999) Am J Respir Crit Care Med. 160(6):1856-1861.
Luigi G F. Clive P P. Bartolome R C. Mario C. Michael J W. Meindert D K F R. Oscar E D P. (2006) Pulmonary Pharmacology & Therapeutics 19:189-199.
Croxton T L. Weinmann G G. Senior R M. Wise R A. Crapo J D. Buist A S. (2003) Am J Respir Crit Care Med. 167(8):1142-1149.
Quint J K. Wedzicha J A. (2007) J Allergy Clin Immunol. 119:1065-1071.
Gamble E. Grootendorst D C. Hattotuwa K. O'Shaughnessy T. Ram F S F. Qiu Y. (2007) Eur Respir J. 30:467-471.
Baraldo S. Turato G. Badin C. Bazzan E. Beghe B. Zuin R. (2004) Thorax. 59:308-312.
Battaglia S. Mauad T. Van Schadewijk A M. Vignola A M. Rabe K F. Bellia V. (2007) J Clin Pathol. 60:907-911.
Agustí A G. Noguera A. Sauleda J. Sala E. Pons J X B. (2003) Eur Respir J.21:347-360.
Gan W Q. Man S F P. Senthilselvan A. Sin D D. (2004) Thorax. 59:574-580.
Franciosi L G. Page C P. Celli B R. Cazzola M. Walker M J. Danhot M. (2006) Pulm Pharmacol & Ther.19:189-199.
Takabatake N. Nakamura H. Abe S. Hino T. Saito H.Yuki H. (1999) Am J Respir Crit Care Med. 159:1215- 1219.
Pinto-Plata V M. Mullerova H. Toso J F. Feudjo-Tepie M.Soriano J B. Vessey R S. (2006) Thorax. 61:23-28.
Higashimoto Y. Yamagata Y. Taya S. Iwata T. Okada M. Ishiguchi T. (2008) Respirology. 13:128-133.
Churg A. Dai J. Tai H. Xie C S. Wright J L. (2002) Am J Respir Crit Care Med. 166:849-854.
Mukhopadhyay S, Hoidal J R, Mukherjee T K. (2006) Respir Res. 7:125.
Vernooy J H. Kucukaycan M. Jacobs J A. Chavannes N H. Buurman W A. Dentener MA. (2002) Am J Respir Crit Care Med. 166:1218-1224.
Tanni S E. Nilva R G P. Aparecida Y O A. Camila C.Irma G. (2010) Journal of Inflammation. 7:29.
Singh B. Arora S. Khanna V. (2010) Monaldi Arch Chest Dec.73: 2, 86-87.
Barnes P J. (2008) Nat Rev Immunol 2008; 8: 183-92.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array